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Palladium-catalyzed asymmetric conjugate additions are an increasingly versatile class of
enantioselective reactions that allow for stereoselective alkylation and arylation of α,β-
unsaturated conjugate acceptors.[1] These processes often utilize easily-handled, air- and
water-stable boron nucleophiles that render these reactions highly tolerant of oxygen and
moisture.[2] Recently, our group disclosed the asymmetric conjugate addition of arylboronic
acids to cyclic enones facilitated by a palladium catalyst derived in situ from palladium(II)
trifluoroacetate and a chiral pyridinooxazoline (PyOX) ligand (5).[3] Notably, our catalyst
system was generally applicable for 5-, 6-, and 7-membered carbocyclic enones. The
numerous advantages of this system encouraged us to seek application to heterocyclic
molecules, in order to demonstrate the broad utility of this reaction for the synthesis of
pharmaceutically relevant molecules. Herein, we report the first general enantioselective
conjugate addition of arylboronic acids to heterocyclic conjugate acceptors derived from
chromones and 4-quinolones utilizing the Pd/PyOX catalyst system. These reactions are
performed under an atmosphere of air and deliver a large variety of asymmetric products
with high enantioselectivity in moderate to excellent yields. The stereoselective conversion
of chromones through conjugate addition renders access to flavanones, a class of
heterocyclic molecules that have demonstrated numerous medicinal properties.[4] Recent
literature suggests that intramolecular oxa-Michael additions are among the best-studied
synthetic methods for asymmetric flavanone synthesis.[5] However, examples for the
retrosynthetic disconnection of flavanones via conjugate addition of an aryl moiety to a
chromone derivative remain scarce.[6,7] While chromones have been successfully employed
in rhodium-catalyzed conjugate addition,[7] to the best of our knowledge, no palladium-
catalyzed asymmetric conjugate addition syntheses of flavanones have been reported.[8] We
identified chromone as a functioning conjugate acceptor with our Pd/PyOX system during a
screen developed to analyze the effect of a β-substituent on reactivity and enantioselectivity
(Table 1). As reported in our initial communication,[3] 3-methylcyclohexenone reacts with
phenylboronic acid to give nearly quantitative yield of the conjugate addition adduct 2 in
93% ee (entry 2). With only hydrogen in the β-position, enantioselectivity drops
precipitously to 18% ee (entry 1). Interestingly, 2-methyl-4-chromone reacts poorly, with
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only trace conjugate addition adduct detected by 1H NMR spectroscopy (entry 4), yet
chromone reacts with high yield and excellent enantioselectivity (94% ee, entry 3).
We sought to explore the scope of the asymmetric conjugate addition of arylboronic acids to
chromones with respect to the range of substrates and functional groups tolerated. Moderate
yields and enantioselectivity were realized with sterically challenging 2-fluorophenylboronic
acid (entry 2). Arylboronic acid substitution at the meta position is generally tolerated with
high enantioselectivity and moderate to good yields (entries 3–7). Notably, arylboronic acids
with halogen substitutents in the para position (entry 10) and 3-carbomethoxyphenylboronic
acid undergo conjugate addition with high enantioselectivity (entry 4). Furthermore,
nitrogen-containing substitution was well tolerated when protected as a trifluoroacetamide,
producing the flavanone in 77% yield and 98% ee (entry 6). Other para-substituted
arylboronic acids also reacted with high enantioselectivity: alkyl substituents on the
phenylboronic acid yielded 94% and 85% ee (entries 8 and 9, respectively). With 3,5-
dimethoxyphenylboronic acid, bearing multiple substituents, high enantioselectivity (95%
ee) was obtained (entry 10). Remarkably, a heteroarylboronic acid was successfully reacted
with chromone as the conjugate acceptor for the first time (entry 12), as 4-
dibenzofuranboronic acid was converted with 64% yield and 77% ee in this case.
Substituted chromones were also found to perform well with the PyOX/Pd catalytic system.
5,7-dimethyl-6-acetylchromone was successfully converted with a variety of arylboronic
acids (Table 3, i.e., 6–8). Addition of phenylboronic acid gave nearly quantitative yield and
90% ee (6), while 3-methylphenylboronic acid saw diminished yield with comparable ee of
88% (7), and 4-ethylphenylboronic acid reacted with modest yield and 86% ee (8).
Furthermore, a variety of para- and meta-substituted arylboronic acids were successfully
converted with the corresponding 5,7-dimethyl-8-acetylchromone as well (i.e., 9–14).
Nucleophiles bearing functional group handles such as 3-carbomethoxy-phenylboronic acid
and 3-bromophenylboronic acid reacted to yield flavanone products 13 and 11 respectively
with good to moderate yield (60% and 65%) and high ee (i.e., 86% and 95%). Notably, with
the present catalytic protocol 7-hydroxychromone could be successfully applied, yielding
flavanones 18, 19, and 20 without protection of the phenol (Table 3). To our knowledge, this
is the first example of an unprotected phenol reacted in asymmetric conjugate additions and
serves to highlight the high functional group tolerance as compared to other systems.[7] 7-
hydroxychromone underwent smooth conjugate addition with a range of boronic acids in
good yield and enantioselectivity: phenylboronic acid (18, 77% yield, 93% ee), 3-
methylphenylboronic acid (19, 66% yield, 90% ee), and 4-fluorophenylboronic acid (20,
50% yield, 93% ee). Finally, we found reaction of phenylboronic acids with substituted
chromones to be general for a number of other substituted chromones including 5,7-
dimethylchromone (flavanones 15 and 16, 92% ee and 95% ee), 7-acetoxychromone
(flavanone 17, 93% ee) and 7-methoxychromone (flavanones 21 and 22, 94% ee and 96%
ee).
We next turned our attention to 4-quinolones as a class of potential substrates. Like
flavanones, 4-quinolones have been reported as potential pharmaceutical agents.[9] Yet,
despite their promising antimitotic and antitumor activity, the enantioselective synthesis of
2-aryl-2,3-dihydro-4-quinolones remains a challenge in asymmetric conjugate addition.
Hayashi and co-workers reported a rhodium-catalyzed asymmetric conjugate addition,
which utilized 3 equivalents of arylzinc chloride nucleophiles and superstoichiometic
chlorotrimethylsilane to react with Cbz-protected 4-quinolones.[10] While Hayashi notes that
phenylboronic acid is a particularly poor nucleophile in reactions with protected 4-
quinolones, giving the desired conjugate addition adduct in only 10% yield, Liao and co-
workers reportedrhodium-catalyzed asymmetric 1,4-addition of sodium tetraarylborate
reagents to N-substituted 4-quinolones.[11] To the best of our knowledge, there are no
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literature reports of palladium-catalyzed conjugate additions to 4-quinolones, nor are there
any robust examples of additions to the latter utilizing simple boronic acid nucleophiles.
To our delight, Carboxybenzyl-protected (Cbz) 4-quinolone reacted with phenylboronic acid
to yield conjugate addition adduct 23 in modest yield and 80% ee (Table 4). Investigation of
further N-protecting groups demonstrated that the Carboxybenzyl-protected substrates gave
the best results in terms of reactivity and stereoselectivity. Gratifyingly, a range of addition
products could be prepared in yields up to 65% yield and 89% ee (Table 4). Nitrogen-
containing, heteroaromatic and simpler boronic acid derivatives were successfully employed
as nucleophiles in the 1,4-addition to 4-quinolones. For the corresponding alkyl- and
halogen-substituted boronic acids, reasonable yields (45–65%) and enantioselectivities (67–
89% ee) were observed in the conjugate addition of 4-quinolones.
Disubstituted boronic acids were well tolerated and gave similar results (24 and 26). Both
compounds were obtained in 85% ee. For addition products 27, 30, and 31 yields and
enantioselectivities ranging from 31% to 36% and 40% to 60% ee were achieved (Table 4).
While the decreased yield of quinolone 31 can be rationalized by the sterically demanding
nature of the boronic acid, the lower ee could not be readily explained.
To confirm the homogenous nature of our catalyst system and exclude the possibility of
erosion of enantiomeric excess due to the presence of catalytically active, achiral Pd
nanoparticles, a mercury drop test was performed. The addition of mercury to a catalytic
reaction is widely used to exclude catalysis by Pd-nanoparticles as the amalgation should
only deactivate heterogenous metal particles.[12] For the conversion of chromone with
phenylboronic acid in presence of 200 equiv of mercury, with respect to the catalyst, only a
slight drop of the yield from 91% to 80% was observed, while the ee of 94% remained
unaltered. Addition of mercury to the reaction of 3-Me-cyclohexenone and phenylboronic
acid resulted in quantitative yield and a slightly reduced ee of 90% for addition product 2,
which is within error margins. Hence, the formation of zerovalent Pd-nanoparticles could be
excluded.
In conclusion, we report the palladium-catalyzed conjugate addition of arylboronic acids to
chromones and 4-quinolones using a single, easily prepared catalyst system. To our
knowledge this is the first report of a palladium-catalyzed asymmetric conjugate addition to
chromones and 4-quinolones using either palladium catalysis or arylboronic acid
nucleophiles. Overall, a total of 38 addition products could be synthesized in moderate to
excellent yield and high enantioselectivity. The present catalytic protocol exhibits
particularly mild reaction conditions and renders the use of silver salts for catalyst activation
obsolete. Furthermore, moisture and air are well tolerated; this results in an unprecedented
functional group tolerance. Hence, the direct synthesis of flavanones bearing free hydroxyl-
groups via conjugate addition and the application of N-substituted, as well as heterocyclic
boronic acids, is realized. We are currently conducting kinetic and computational studies to
elucidate the present catalytic reaction mechanism. Furthermore, continued study of the
substrate scope of the Pd/PyOX system and its reactivity, as well as the application of these
operationally simple asymmetric conjugate addition reactions to total synthesis are
underway in our laboratory.
Experimental Section
Representative General Procedure for the Enantioselective 1,4-Addition of Arylboronic
Acids to Heteroaromatic Conjugate Acceptors
A screw-top 1 dram vial was charged with a stir bar, Pd(OCOCF3)2 (4.2 mg, 0.0125 mmol,
5 mol%), (S)-t-BuPyOX (3.1 mg, 0.015 mmol, 6 mol%), NH4PF6 (12.5 mg, 0.075 mmol, 30
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mol%) and the corresponding arylboronic acid (0.50 mmol, 2.0 equiv). The solids were
suspended in dichloroethane (0.5 mL) and stirred for 2 min at ambient temperature, at which
time a yellow color was observed. Not all solids were dissolved at this time. Conjugate
acceptor substrate (0.25 mmol, 1.0 equiv) and water (0.025 mL, 1.25 mmol, 5.0 equiv) were
added. The walls of the vial were rinsed with an additional portion of dichloroethane (0.5
mL). The vial was capped with a Teflon/silicone septum and stirred at 60 °C in an oil bath
for 12 h. Upon complete consumption of the starting material (monitored by TLC, 4:1
hexanes/EtOAc, p-anisaldehyde or iodine/silica gel stain) the reaction mixture was eluted
through a pipet plug of silica gel, using CH2Cl2 as the eluent, and concentrated in vacuo.
The crude residue was purified by column chromatography (hexanes/EtOAc) to afford a
colorless solid.
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Table 1
Comparison of Asymmetric Conjugate Additions to Various Enone Substrates.[a]
[a]Conditions: chromone (0.25 mmol), arylboronic acid (0.50 mmol), Pd(OCOCF3)2 (5 mol %), Ligand (6 mol %), NH4PF6 (30 mol %), H2O (5
equiv), ClCH2CH2Cl (1 mL), 60 °C, 12 h
[b]isolated yield
[c]
ee determined by chiral SFC or HPLC
[d]
no NH4PF6 was used.
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Table 2
Asymmetric Conjugate Addition of Arylboronic Acids to Chromone.[a]
[a]Conditions: chromone (0.25 mmol), arylboronic acid (0.50 mmol), Pd(OCOCF3)2 (5 mol %), Ligand (6 mol %), N4PF6 (30 mol %), H2O (5
equiv), ClCH2CH2Cl (1 mL), 60 °C, 12 h
[b]isolated yield
[c]
ee determined by chiral SFC.
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Table 3
Asymmetric Conjugate Addition of Arylboronic Acids to Substituted Chromones.[a]
[a]Conditions: chromone (0.25 mmol), arylboronic acid (0.50 mmol), Pd(OCOCF3)2 (5 mol %), Ligand (6 mol %), NH4PF6 (30 mol %), H2O (5
equiv), ClCH2CH2Cl (1 mL), 60 °C, 12 h, yields given are isolated yields, ee determined by chiral SFC.
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Table 4
Asymmetric Conjugate Addition of Arylboronic Acids to 4-Quinolones.[a]
[a]Conditions: 4-quinolone (0.25 mmol), arylboronic acid (0.50 mmol),Pd(OCOCF3)2 (5 mol %), Ligand (6 mol %), NH4PF6 (30 mol %), H2O (5
equiv),ClCH2CH2Cl (1 mL), 60 °C, 12 h, yields given are isolated yields, ee determined by chiral SFC.
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